Compare $APVO vs $MBIO | Chartloom

Compare

$APVO vs $MBIO

Aptevo Therapeutics Inc · Mustang Bio Inc

APVO

Aptevo Therapeutics Inc

MBIO

Mustang Bio Inc

Compare $APVO vs $MBIO

Comparing Aptevo Therapeutics Inc and Mustang Bio Inc

APVOAptevo Therapeutics Inc

MBIOMustang Bio Inc

APVOAptevo Therapeutics Inc

Market cap

$2M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-80.9%

52W performance

-94.2%

FCF yield

-1132.6%

MBIOMustang Bio Inc

Market cap

$3M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-62.6%

52W performance

-77.0%

FCF yield

-148.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

APVO

MBIO

Detailed metrics comparison

APVO

Aptevo Therapeutics Inc

MBIO

Mustang Bio Inc

Market Cap

APVO$2M

MBIO$3M

Enterprise Value

APVO$-8M

MBIO$-12M

Price

APVO$1.79

MBIO$0.40

P/E Ratio

APVON/A

MBION/A

P/S Ratio

APVO0.25x

MBIO0.00x

EV/Sales

APVO-0.51x

MBIO0.00x

EV/EBITDA

APVO-0.91x

MBIO0.00x

P/B Ratio

APVO0.53x

MBIO0.47x

P/FCF Ratio

APVON/A

MBION/A

EV/FCF

APVO0.30x

MBIO2.69x

PEG Ratio

APVON/A

MBION/A

Forward P/E (NTM)

APVON/A

MBION/A

Forward P/S (NTM)

APVON/A

MBION/A

Revenue (TTM)

APVO$0

MBIO$0

Revenue Growth (YoY)

APVON/A

MBION/A

Forward Rev Growth

APVO206.8%

MBIO0.0%

Gross Margin (TTM)

APVO51.4%

MBIO0.0%

Operating Margin (TTM)

APVO0.0%

MBIO0.0%

EBITDA Margin (TTM)

APVO0.0%

MBIO0.0%

Net Margin (TTM)

APVO0.0%

MBIO0.0%

FCF Margin (TTM)

APVON/A

MBION/A

Net Income (TTM)

APVO$-28M

MBIO$-3M

FCF (TTM)

APVO$-25M

MBIO$-5M

EPS (TTM)

APVO-$23.47

MBIO-$0.45

ROE (TTM)

APVO-20149.0%

MBIO-3423.0%

ROA (TTM)

APVO-11921.0%

MBIO-1754.0%

ROIC (TTM)

APVO-20149.0%

MBIO-3423.0%

Cash

APVO$10M

MBIO$15M

Debt

APVO$0

MBIO$0

Net Cash/Debt

APVO$10M

MBIO$15M

Current Ratio (TTM)

APVO2.08x

MBIO1.97x

Quick Ratio (TTM)

APVO1.98x

MBIO1.94x

Debt/Equity (TTM)

APVO0.00x

MBIO0.00x

Debt/Assets (TTM)

APVO0.0%

MBIO0.0%

Interest Coverage (TTM)

APVON/A

MBION/A

Net Debt/EBITDA (TTM)

APVO0.00x

MBIO0.00x

Beta

APVO1.68

MBIO2.19

52W Performance

APVO-94.2%

MBIO-77.0%

YTD Performance

APVO-80.9%

MBIO-62.6%

% from 52W High

APVO-94.6%

MBIO-78.4%

% from 52W Low

APVO30.7%

MBIO5.2%

Asset Turnover (TTM)

APVO0.22x

MBIO0.00x

FCF Yield (TTM)

APVO-1132.6%

MBIO-148.7%

Earnings Yield (TTM)

APVO-1254.8%

MBIO-100.0%

Dividend Yield (TTM)

APVON/A

MBION/A

Rule of 40

APVO0.0

MBIO0.0

EV/GP/RG

APVON/A

MBION/A

Ticker research

View APVO research View MBIO research

Metric	APVO Aptevo Therapeutics Inc	MBIO Mustang Bio Inc
Market & Valuation
Market Cap	$2M	$3M
Enterprise Value	$-8M	$-12M
Price	$1.79	$0.40
P/E Ratio	N/A	N/A
P/S Ratio	0.25x	0.00x
EV/Sales	-0.51x	0.00x
EV/EBITDA	-0.91x	0.00x
P/B Ratio	0.53x	0.47x
P/FCF Ratio	N/A	N/A
EV/FCF	0.30x	2.69x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	206.8%	0.0%
Profitability
Gross Margin (TTM)	51.4%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-28M	$-3M
FCF (TTM)	$-25M	$-5M
EPS (TTM)	-$23.47	-$0.45
ROE (TTM)	-20149.0%	-3423.0%
ROA (TTM)	-11921.0%	-1754.0%
ROIC (TTM)	-20149.0%	-3423.0%
Financial Health
Cash	$10M	$15M
Debt	$0	$0
Net Cash/Debt	$10M	$15M
Current Ratio (TTM)	2.08x	1.97x
Quick Ratio (TTM)	1.98x	1.94x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.68	2.19
52W Performance	-94.2%	-77.0%
YTD Performance	-80.9%	-62.6%
% from 52W High	-94.6%	-78.4%
% from 52W Low	30.7%	5.2%
Efficiency & Yields
Asset Turnover (TTM)	0.22x	0.00x
FCF Yield (TTM)	-1132.6%	-148.7%
Earnings Yield (TTM)	-1254.8%	-100.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View APVO research	View MBIO research

Valuation

P/S Ratio

MBIO

0.00x

APVO

0.25x

EV/FCF

APVO

0.30x

MBIO

2.69x

Growth & revenue

Forward Revenue Growth

APVO

206.8%

MBIO

0.0%

Profitability & performance

Gross Margin

APVO

51.4%

MBIO

0.0%

ROE

MBIO

-3423.0%

APVO

-20149.0%

FCF Yield %

MBIO

-148.7%

APVO

-1132.6%

52-Week Performance

MBIO

-77.0%

APVO

-94.2%

Detailed metrics comparison

APVO

Aptevo Therapeutics Inc

MBIO

Mustang Bio Inc

Market Cap

APVO$2M

MBIO$3M

Enterprise Value

APVO$-8M

MBIO$-12M

Price

APVO$1.79

MBIO$0.40

P/E Ratio

APVON/A

MBION/A

P/S Ratio

APVO0.25x

MBIO0.00x

EV/Sales

APVO-0.51x

MBIO0.00x

EV/EBITDA

APVO-0.91x

MBIO0.00x

P/B Ratio

APVO0.53x

MBIO0.47x

P/FCF Ratio

APVON/A

MBION/A

EV/FCF

APVO0.30x

MBIO2.69x

PEG Ratio

APVON/A

MBION/A

Forward P/E (NTM)

APVON/A

MBION/A

Forward P/S (NTM)

APVON/A

MBION/A

Revenue (TTM)

APVO$0

MBIO$0

Revenue Growth (YoY)

APVON/A

MBION/A

Forward Rev Growth

APVO206.8%

MBIO0.0%

Gross Margin (TTM)

APVO51.4%

MBIO0.0%

Operating Margin (TTM)

APVO0.0%

MBIO0.0%

EBITDA Margin (TTM)

APVO0.0%

MBIO0.0%

Net Margin (TTM)

APVO0.0%

MBIO0.0%

FCF Margin (TTM)

APVON/A

MBION/A

Net Income (TTM)

APVO$-28M

MBIO$-3M

FCF (TTM)

APVO$-25M

MBIO$-5M

EPS (TTM)

APVO-$23.47

MBIO-$0.45

ROE (TTM)

APVO-20149.0%

MBIO-3423.0%

ROA (TTM)

APVO-11921.0%

MBIO-1754.0%

ROIC (TTM)

APVO-20149.0%

MBIO-3423.0%

Cash

APVO$10M

MBIO$15M

Debt

APVO$0

MBIO$0

Net Cash/Debt

APVO$10M

MBIO$15M

Current Ratio (TTM)

APVO2.08x

MBIO1.97x

Quick Ratio (TTM)

APVO1.98x

MBIO1.94x

Debt/Equity (TTM)

APVO0.00x

MBIO0.00x

Debt/Assets (TTM)

APVO0.0%

MBIO0.0%

Interest Coverage (TTM)

APVON/A

MBION/A

Net Debt/EBITDA (TTM)

APVO0.00x

MBIO0.00x

Beta

APVO1.68

MBIO2.19

52W Performance

APVO-94.2%

MBIO-77.0%

YTD Performance

APVO-80.9%

MBIO-62.6%

% from 52W High

APVO-94.6%

MBIO-78.4%

% from 52W Low

APVO30.7%

MBIO5.2%

Asset Turnover (TTM)

APVO0.22x

MBIO0.00x

FCF Yield (TTM)

APVO-1132.6%

MBIO-148.7%

Earnings Yield (TTM)

APVO-1254.8%

MBIO-100.0%

Dividend Yield (TTM)

APVON/A

MBION/A

Rule of 40

APVO0.0

MBIO0.0

EV/GP/RG

APVON/A

MBION/A

Ticker research

View APVO research View MBIO research

Metric	APVO Aptevo Therapeutics Inc	MBIO Mustang Bio Inc
Market & Valuation
Market Cap	$2M	$3M
Enterprise Value	$-8M	$-12M
Price	$1.79	$0.40
P/E Ratio	N/A	N/A
P/S Ratio	0.25x	0.00x
EV/Sales	-0.51x	0.00x
EV/EBITDA	-0.91x	0.00x
P/B Ratio	0.53x	0.47x
P/FCF Ratio	N/A	N/A
EV/FCF	0.30x	2.69x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	206.8%	0.0%
Profitability
Gross Margin (TTM)	51.4%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-28M	$-3M
FCF (TTM)	$-25M	$-5M
EPS (TTM)	-$23.47	-$0.45
ROE (TTM)	-20149.0%	-3423.0%
ROA (TTM)	-11921.0%	-1754.0%
ROIC (TTM)	-20149.0%	-3423.0%
Financial Health
Cash	$10M	$15M
Debt	$0	$0
Net Cash/Debt	$10M	$15M
Current Ratio (TTM)	2.08x	1.97x
Quick Ratio (TTM)	1.98x	1.94x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.68	2.19
52W Performance	-94.2%	-77.0%
YTD Performance	-80.9%	-62.6%
% from 52W High	-94.6%	-78.4%
% from 52W Low	30.7%	5.2%
Efficiency & Yields
Asset Turnover (TTM)	0.22x	0.00x
FCF Yield (TTM)	-1132.6%	-148.7%
Earnings Yield (TTM)	-1254.8%	-100.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View APVO research	View MBIO research